Testosterone, SHBG and cardiovascular health in postmenopausal women
International Journal of Impotence Research:
similar ...
Erectile dysfunction in a Mediterranean country: results of an epidemiological survey of a representative sample of men
International Journal of Impotence Research:
similar ...
Clinically meaningful improvement on the quality of erection questionnaire in men with erectile dysfunction
International Journal of Impotence Research:
similar ...
Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men
International Journal of Impotence Research:
similar ...
Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire
International Journal of Impotence Research:
similar ...
Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses
International Journal of Impotence Research:
similar ...
Impact of gynecological surgery on female sexual function
International Journal of Impotence Research:
similar ...
Protalix drug recommended for special status
Drug News: Impotence, Arthritis and Schizophrenia
Research from University of Pittsburgh, U.S., yields new healthcare findings
New data from University of Perugia, Italy, studies illuminate research
Studies to date say erectile dysfunction drugs affect other systems, mostly for the better
Researchers from Cedars-Sinai Medical Center, Los Angeles publish recent findings
p38 MAPK inhibition corrects indices of diabetic erectile autonomic neuropathy and vasculopathy
Erectile dysfunction is reversed by angiogenic gene therapy in hypercholesterolemia models
Cialis Filed in European Union for Once-a-Day Dosing for Erectile Dysfunction; ICOS Expects Significant Acceleration of Earnings in 2007 and 2008
Erectile dysfunction models benefit from intracavernosal basic fibroblast growth factor
NT3 gene therapy applicable for treatment of diabetes-induced ED
Recent findings in endocrinology described
Dong-A PharmTech presents Phase II data on new erectile dysfunction drug at the 11th World Congress of the ISSIR.
CHEMICAL BUSINESS NEWSBASE - PRESS RELEASE:
similar ...
